197 related articles for article (PubMed ID: 33080041)
1. Zafirlukast is a broad-spectrum thiol isomerase inhibitor that inhibits thrombosis without altering bleeding times.
Holbrook LM; Keeton SJ; Sasikumar P; Nock S; Gelzinis J; Brunt E; Ryan S; Pantos MM; Verbetsky CA; Gibbins JM; Kennedy DR
Br J Pharmacol; 2021 Feb; 178(3):550-563. PubMed ID: 33080041
[TBL] [Abstract][Full Text] [Related]
2. Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic.
Gelzinis JA; Szahaj MK; Bekendam RH; Wurl SE; Pantos MM; Verbetsky CA; Dufresne A; Shea M; Howard KC; Tsodikov OV; Garneau-Tsodikova S; Zwicker JI; Kennedy DR
FASEB J; 2023 May; 37(5):e22914. PubMed ID: 37043381
[TBL] [Abstract][Full Text] [Related]
3. A humanized monoclonal antibody that inhibits platelet-surface ERp72 reveals a role for ERp72 in thrombosis.
Holbrook LM; Sandhar GK; Sasikumar P; Schenk MP; Stainer AR; Sahli KA; Flora GD; Bicknell AB; Gibbins JM
J Thromb Haemost; 2018 Feb; 16(2):367-377. PubMed ID: 29052936
[TBL] [Abstract][Full Text] [Related]
4. Thiol isomerases in thrombus formation.
Furie B; Flaumenhaft R
Circ Res; 2014 Mar; 114(7):1162-73. PubMed ID: 24677236
[TBL] [Abstract][Full Text] [Related]
5. The platelet-surface thiol isomerase enzyme ERp57 modulates platelet function.
Holbrook LM; Sasikumar P; Stanley RG; Simmonds AD; Bicknell AB; Gibbins JM
J Thromb Haemost; 2012 Feb; 10(2):278-88. PubMed ID: 22168334
[TBL] [Abstract][Full Text] [Related]
6. Platelets release novel thiol isomerase enzymes which are recruited to the cell surface following activation.
Holbrook LM; Watkins NA; Simmonds AD; Jones CI; Ouwehand WH; Gibbins JM
Br J Haematol; 2010 Feb; 148(4):627-37. PubMed ID: 19995400
[TBL] [Abstract][Full Text] [Related]
7. Vascular thiol isomerases: Structures, regulatory mechanisms, and inhibitor development.
Liang C; Flaumenhaft R; Yuan C; Huang M
Drug Discov Today; 2022 Feb; 27(2):626-635. PubMed ID: 34757205
[TBL] [Abstract][Full Text] [Related]
8. Vascular thiol isomerases in thrombosis: The yin and yang.
Wu Y; Essex DW
J Thromb Haemost; 2020 Nov; 18(11):2790-2800. PubMed ID: 32702157
[TBL] [Abstract][Full Text] [Related]
9. Protein disulfide isomerase regulation by nitric oxide maintains vascular quiescence and controls thrombus formation.
Bekendam RH; Iyu D; Passam F; Stopa JD; De Ceunynck K; Muse O; Bendapudi PK; Garnier CL; Gopal S; Crescence L; Chiu J; Furie B; Panicot-Dubois L; Hogg PJ; Dubois C; Flaumenhaft R
J Thromb Haemost; 2018 Nov; 16(11):2322-2335. PubMed ID: 30207066
[TBL] [Abstract][Full Text] [Related]
10. Platelet-targeting thiol reduction sensor detects thiol isomerase activity on activated platelets in mouse and human blood under flow.
Zhu S; Welsh JD; Brass LF; Diamond SL
J Thromb Haemost; 2016 May; 14(5):1070-81. PubMed ID: 26725377
[TBL] [Abstract][Full Text] [Related]
11. Thiol Isomerases Orchestrate Thrombosis and Hemostasis.
Gaspar RS; Gibbins JM
Antioxid Redox Signal; 2021 Nov; 35(13):1116-1133. PubMed ID: 33940944
[No Abstract] [Full Text] [Related]
12. Regulatory role of thiol isomerases in thrombus formation.
Sharda A; Furie B
Expert Rev Hematol; 2018 May; 11(5):437-448. PubMed ID: 29542339
[TBL] [Abstract][Full Text] [Related]
13. The transmembrane protein disulfide isomerase TMX1 negatively regulates platelet responses.
Zhao Z; Wu Y; Zhou J; Chen F; Yang A; Essex DW
Blood; 2019 Jan; 133(3):246-251. PubMed ID: 30425049
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in vascular thiol isomerases and redox systems in platelet function and thrombosis.
Essex DW; Wang L
J Thromb Haemost; 2024 Mar; ():. PubMed ID: 38518897
[TBL] [Abstract][Full Text] [Related]
15. Functional Assays of Thiol Isomerase ERp5.
Dupuy A; Passam F
Methods Mol Biol; 2019; 1967():149-163. PubMed ID: 31069769
[TBL] [Abstract][Full Text] [Related]
16. Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents.
Jasuja R; Passam FH; Kennedy DR; Kim SH; van Hessem L; Lin L; Bowley SR; Joshi SS; Dilks JR; Furie B; Furie BC; Flaumenhaft R
J Clin Invest; 2012 Jun; 122(6):2104-13. PubMed ID: 22565308
[TBL] [Abstract][Full Text] [Related]
17. Both platelet- and endothelial cell-derived ERp5 support thrombus formation in a laser-induced mouse model of thrombosis.
Passam FH; Lin L; Gopal S; Stopa JD; Bellido-Martin L; Huang M; Furie BC; Furie B
Blood; 2015 Apr; 125(14):2276-85. PubMed ID: 25624318
[TBL] [Abstract][Full Text] [Related]
18. Molecular docking-assisted screening reveals tannic acid as a natural protein disulphide isomerase inhibitor with antiplatelet and antithrombotic activities.
Ren L; You T; Li Q; Chen G; Liu Z; Zhao X; Wang Y; Wang L; Wu Y; Tang C; Zhu L
J Cell Mol Med; 2020 Dec; 24(24):14257-14269. PubMed ID: 33128352
[TBL] [Abstract][Full Text] [Related]
19. Platelet protein disulfide isomerase is required for thrombus formation but not for hemostasis in mice.
Kim K; Hahm E; Li J; Holbrook LM; Sasikumar P; Stanley RG; Ushio-Fukai M; Gibbins JM; Cho J
Blood; 2013 Aug; 122(6):1052-61. PubMed ID: 23788140
[TBL] [Abstract][Full Text] [Related]
20. Endoplasmic reticulum protein 5 attenuates platelet endoplasmic reticulum stress and secretion in a mouse model.
Lay AJ; Dupuy A; Hagimola L; Tieng J; Larance M; Zhang Y; Yang J; Kong Y; Chiu J; Gray E; Qin Z; Schmidt D; Maclean J; Hofma B; Ellis M; Kalev-Zylinska M; Argon Y; Jackson SP; Hogg P; Passam FH
Blood Adv; 2023 May; 7(9):1650-1665. PubMed ID: 36508284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
